Sökning: "Tufve Nyholm"
Visar resultat 6 - 10 av 12 avhandlingar innehållade orden Tufve Nyholm.
6. Perfusion MRI of the brain after radiotherapy in patients with glioblastoma – potential and problems
Sammanfattning : Perfusion Magnetic Resonance Imaging (MRI) is a useful tool in diagnostic evaluation and treatment response assessment in patients with glioblastoma. The standard treatment regimen includes surgical resection, radiotherapy and adjuvant chemotherapy. However, prognosis is poor; relative 5-year survival is 3–5%. LÄS MER
7. Magnetic resonance imaging with ultrashort echo time as a substitute for X-ray computed tomography
Sammanfattning : Radiotherapy dose calculations have evolved from simple factor based methods performed with pen and paper, into computationally intensive simulations based on Monte Carlo theory and energy deposition kernel convolution.Similarly, in the field of positron emission tomography (PET), attenuation correction, which was originally omitted entirely, is now a crucial component of any PET reconstruction algorithm. LÄS MER
8. Integration of MRI into the radiotherapy workflow
Sammanfattning : The modern day radiotherapy treatments are almost exclusively based on computed tomography (CT) images. The CT images are acquired using x-rays, and therefore reflect the radiation interaction properties of the material. LÄS MER
9. Geometric distortions in MRI based radiotherapy and PET/MRI
Sammanfattning : Magnetic resonance imaging (MRI) offers high soft-tissue contrast compared to computed tomography (CT). This contrast is helpful in many cases, not least for delineating tumours for radiotherapy treatment, and has led to increasing use in radiotherapy treatment planning (RTP). LÄS MER
10. PET and MR imaging in prostate cancer
Sammanfattning : The current risk assessment of prostate cancer (PC) relies on histopathological samples from biopsies and clinical variables such as prostate-specific antigen (PSA). However, this comes with uncertainties and in some cases it can be challenging to separate patients who would benefit from radical treatment and those who would not. LÄS MER